In the last trading session, 2.5 million Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.93. With the company’s per share
In last trading session, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) saw 3.3 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has a beta value of 1.94 and has seen 1.78 million shares traded in the last trading session. The company, currently
During the last session, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX)’s traded shares were 3.06 million, with the beta value of the company hitting 1.93. At the end
In the last trading session, 3.48 million shares of the Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) were traded, and its beta was 1.90. Most recently the company’s
In the latest trading session,, 0.56 million Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.91. With the company’s most recent
In recent trading session, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) saw 0.67 million shares changing hands at last check today with its beta currently measuring 1.91. Company’s
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has a beta value of 1.92 and has seen 0.62 million shares traded in the recent trading session. The company, currently
During the last session, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX)’s traded shares were 4.04 million, with the beta value of the company hitting 1.92. At the end
In the last trading session, 2.95 million shares of the Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) were traded, and its beta was 1.92. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
